ArticleHeliyon2024

Coexistence of a novel SRBD1-ALK, ALK-CACNA1D double-fusion in a lung adenocarcinoma patient and response to alectinib: A case report.

Xiaohong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.